Patent · US Active

Streptavidin muteins and methods of using them

US10844099B2 · kind B2 · utility

1Cited by
4References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 27, 2018
Grant dateNov 24, 2020
Priority date—
Expiry dateJul 27, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/36
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention concerns novel streptavidin muteins. In one embodiment such a mutein(a) contains two or more mutations in the region of the amino acid positions 117 to 121 with reference to the amino acid sequence of wild type streptavidin of which amino acid residues 14 to 139 are as set forth at SEQ ID NO:212 and(b) has a higher binding affinity than each of(i) a streptavidin mutein “1” (SEQ ID NO: 16) that comprises the amino acid sequence Val44-Thr45-Ala46-Arg47 (SEQ ID NO: 98), or(ii) wild type-streptavidin of which amino acid residues 14 to 139 are shown as SEQ ID NO: 212for peptide ligands comprising the amino acid sequence Trp-Ser-His-Pro-Gln-Phe-Glu-Lys (SEQ ID NO: 100).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.